Overview

Gender

female

Ros Deegan, MBA, is president and chief business officer of Bicycle Therapeutics Inc., the U.S. subsidiary of Bicycle Therapeutics.
Prior to joining Bicycle, Ros most recently served on the senior leadership team at Trevena, Inc. as senior vice president, business development and operations, and previously held the role of head of finance and operations. While at Trevena, she was responsible for start-up operations, negotiating a significant option and license agreement with Forest Laboratories, Inc., and leading finance and human resources through to the company’s first S-1 filing with the Securities and Exchange Commission. During her tenure, the company moved three programmes into the clinic, and raised over $200 million in private and public financings. Prior to joining Trevena, Ros served as director of business development at GSK in the U.S., leading transactions for the virtual immuno-inflammation group. Prior to that, she served as the director of operations for the Centre of Excellence for External Drug Discovery (CEEDD) and as marketing manager for GSK’s U.K. launch of Bonviva for post-menopausal osteoporosis and in business development.
Ros holds a first-class degree from Cambridge University and received her MBA with distinction from INSEAD.